SCHEMBL10263246

SCHEMBL10263246

N#Cc1ccc(NC(=O)c2ccc3ccc(Oc4ccnc(N)c4)cc3c2)cc1CF

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 2/20 0.40
BRAF P15056 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
KCNQ3 O43525 1/20 0.38
KCNQ2 O43526 1/20 0.38
KCNE1 P15382 1/20 0.38
KCNQ1 P51787 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10200427 0.86 KDR (0.53) BRAFHDAC3HDAC4HDAC1HDAC7
SCHEMBL545646 0.76 RAF1 (0.56) METBRAFHDAC3HDAC4HDAC1
Hydrochloric Acid SCHEMBL545435 0.75 RAF1 (0.55) METBRAFHDAC3HDAC4HDAC1
SCHEMBL5424081 0.74 KDR (0.60) BRAFKDR
SCHEMBL10262734 0.74 P2RX3 (0.44) BRAFHDAC3HDAC4HDAC1HDAC7
SCHEMBL545301 0.73 KDR (0.59) BRAFKDR
SCHEMBL545714 0.73 KDM4E (0.52) BRAFHDAC3HDAC4HDAC1HDAC7
SCHEMBL10263998 0.72 KDR (0.55) BRAFKDR
SCHEMBL10262752 0.71 KMT2A (0.39) BRAFHDAC3HDAC4HDAC1HDAC7
SCHEMBL10262556 0.70 AXL (0.41) METBRAFHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110687-B2 Bicyclic compounds with kinase inhibitory activity MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-02-07 US disclosed